Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001716774-26-000021
Filing Date
2026-07-29
Accepted
2026-07-29 09:48:08
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6967
  Complete submission text file 0001716774-26-000021.txt   8921
Mailing Address ZERNIKEDREEF 9 LEIDEN Netherlands
Business Address ZERNIKEDREEF 9 LEIDEN Netherlands 31 88 166 7000
ProQR Therapeutics N.V. (Subject) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88671 | Film No.: 261214330
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 GEORGE STREET EDINBURGH X0 EH2 2LL
Business Address 1 GEORGE STREET EDINBURGH X0 EH2 2LL 0131 245 2552
Aberdeen Group plc (Filed by) CIK: 0001716774 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G